It is therefore possible that sequence variants in ANK3 and DGKH alter the functions of their encoded proteins in this pathway, disrupting downstream neural processes that lead to the emergence of BD symptoms, and that mood stabilizers mediate their clinical effect through normalizing pathway signaling. This evidence concerns the gene DGKH and Behcet disease.